JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 39 No. 8 1348-1353
© 1998 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moriwaki, H.
Right arrow Articles by Nishimura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moriwaki, H.
Right arrow Articles by Nishimura, T.

Iodine-123-Iomazenil and Iodine-123-lodoamphetamine SPECT in Major Cerebral Artery Occlusive Disease

Hiroshi Moriwaki, Masayasu Matsumoto, Kazuo Hashikawa, Naohiko Oku, Mariko Ishida, Yujiro Seike, Kazuki Fukuchi, Masatsugu Hori and Tsunehiko Nishimura

First Department of Internal Medicine, Department of Neurology, and Division of Nuclear Medicine, Department of Tracer Kinetics, Osaka University Medical School, Suita, Japan

Correspondence: For correspondence or reprints contact: Hiroshi Moriwaki, MD, Cerebrovascular Division, Department of Internal Medicine, National Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita 565, Japan.

ABSTRACT

Iodine-123-iomazenil (IMZ) is a SPECT ligand for central-type benzodiazepine receptors, which are located only on neurons. We evaluated the feasibility of using IMZ SPECT for identifying neuronal damage in patients with the chronic phase of thrombotic cerebral ischemia. Methods: We studied 15 patients with angiographically-confirmed unilateral severe occlusive lesions (occlusion or > 70% stenosis) in the carotid system. IMZ SPECT images obtained 180 min after injection of 167–222 MBq IMZ were analyzed. The regional cerebral blood flow and perfusion reserve were evaluated for com parison with IMZ SPECT findings, using the split-dose 123I-odoamphetamine (IMP) SPECT method, coupled with intravenous injection of 1 g acetazolamide. On both SPECT images, the count ratio of the affected to the nonaffected whole MCA territory (A/NA ratio) and of the contralateral to the ipsilateral cerebellar cortex (C/I ratio) were determined. Results: The A/NA ratio with IMZ was significantly higher than that with IMP (94.5% ± 6.2%versus 91.4% ± 6.6%, p < 0.005), although a significantly positive correlation was found between these two ratios (r = 0.854, p < 0.0001). The C/I ratio with IMP was decreased significantly in 5 patients compared with that in normal subjects, whereas the C/I ratio with IMZ was decreased in only 1 patient. There was no significant correlation between the A/NA ratio with IMZ and the perfusion reserve in the affected MCA territory. In 2 of 5 patients with a decreased A/NA ratio (<90%) with IMZ, decreased blood flow with preserved perfusion reserve and cerebral hemispheric atrophy were observed, which suggested the influence of neuronal loss due to chronic ischemia. Conclusion: These findings indicate that IMZ SPECT, which provides new information regarding neuronal damage after ischemie insult to the brain, is useful for evaluating thrombotic cerebral ischemia.

Key Words: iodine-123-iomazenil • SPECT • cerebral ischemia • diaschisis • perfusion reserve




This article has been cited by other articles:


Home page
StrokeHome page
C. Giffard, B. Landeau, N. Kerrouche, A. R. Young, L. Barre, and J.-C. Baron
Decreased Chronic-Stage Cortical 11C-Flumazenil Binding After Focal Ischemia-Reperfusion in Baboons: A Marker of Selective Neuronal Loss?
Stroke, March 1, 2008; 39(3): 991 - 999.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. Yamauchi, T. Kudoh, Y. Kishibe, J. Iwasaki, and S. Kagawa
Selective Neuronal Damage and Borderzone Infarction in Carotid Artery Occlusive Disease: A 11C-Flumazenil PET Study
J. Nucl. Med., December 1, 2005; 46(12): 1973 - 1979.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
Y. Kaku, S.-i. Yoshimura, and J. Kokuzawa
Factors Predictive of Cerebral Hyperperfusion after Carotid Angioplasty and Stent Placement
AJNR Am. J. Neuroradiol., September 1, 2004; 25(8): 1403 - 1408.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
K. Ogasawara, T. Okuguchi, M. Sasoh, M. Kobayashi, H. Yukawa, K. Terasaki, T. Inoue, and A. Ogawa
Qualitative versus Quantitative Assessment of Cerebrovascular Reactivity to Acetazolamide Using iodine-123-N-Isopropyl-p-Iodoamphetamine SPECT in Patients with Unilateral Major Cerebral Artery Occlusive Disease
AJNR Am. J. Neuroradiol., June 1, 2003; 24(6): 1090 - 1095.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Imaizumi, K. Kitagawa, K. Hashikawa, N. Oku, T. Teratani, M. Takasawa, T. Yoshikawa, P. Rishu, T. Ohtsuki, M. Hori, et al.
Detection of Misery Perfusion With Split-Dose 123I-Iodoamphetamine Single-Photon Emission Computed Tomography in Patients With Carotid Occlusive Diseases
Stroke, September 1, 2002; 33(9): 2217 - 2223.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H Yamauchi, H Fukuyama, Y Dong, H Nabatame, Y Nagahama, S Nishizawa, J Konishi, and H Shio
Atrophy of the corpus callosum associated with a decrease in cortical benzodiazepine receptor in large cerebral arterial occlusive diseases
J. Neurol. Neurosurg. Psychiatry, March 1, 2000; 68(3): 317 - 322.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1998 by the Society of Nuclear Medicine.